53 related articles for article (PubMed ID: 38591189)
1. The EQ-5D-5L valuation study for Trinidad and Tobago.
Bailey H; Jonker MF; Pullenayegum E; Rencz F; Roudijk B
Health Qual Life Outcomes; 2024 Jul; 22(1):51. PubMed ID: 38956543
[TBL] [Abstract][Full Text] [Related]
2. What difference does multiple imputation make in longitudinal modeling of EQ-5D-5L data? Empirical analyses of simulated and observed missing data patterns.
Rösel I; Serna-Higuita LM; Al Sayah F; Buchholz M; Buchholz I; Kohlmann T; Martus P; Feng YS
Qual Life Res; 2022 May; 31(5):1521-1532. PubMed ID: 34797507
[TBL] [Abstract][Full Text] [Related]
3. How Does the New Australian EQ-5D-5L Value Set Impact Utility Scores? Analysis of Data from the Australian Orthopaedic Association National Joint Replacement Registry.
Ackerman IN; Norman R; Harris IA; Cashman K; Lorimer M; Gill S; Lewis P; Soh SE
Appl Health Econ Health Policy; 2024 Jun; ():. PubMed ID: 38878238
[TBL] [Abstract][Full Text] [Related]
4. Health Utility Analysis of Tepotinib in Patients With Non-Small Cell Lung Cancer Harboring MET Exon 14 Skipping.
Yang M; Vioix H; Hook ES; Hatswell AJ; Batteson RL; Gaumond BR; O'Brate A; Popat S; Paik PK
Value Health; 2023 Aug; 26(8):1155-1163. PubMed ID: 36805576
[TBL] [Abstract][Full Text] [Related]
5. A Feasible Estimation of a "Corrected" EQ-5D Social Tariff.
Abellan-Perpiñan JM; Martinez-Perez JE; Sanchez-Martinez FI; Pinto-Prades JL
Value Health; 2024 May; ():. PubMed ID: 38795962
[TBL] [Abstract][Full Text] [Related]
6. Bayesian Meta-Analysis of Health State Utility Values: A Tutorial with a Practical Application in Heart Failure.
Santos JAR; Grant R; Di Tanna GL
Pharmacoeconomics; 2024 Jul; 42(7):721-735. PubMed ID: 38767714
[TBL] [Abstract][Full Text] [Related]
7. ML versus MI for Missing Data with Violation of Distribution Conditions.
Yuan KH; Yang-Wallentin F; Bentler PM
Sociol Methods Res; 2012 Nov; 41(4):598-629. PubMed ID: 24764604
[TBL] [Abstract][Full Text] [Related]
8. Correction: Valuation of the EQ-5D-5L in Taiwan.
Lin HW; Li CI; Lin FJ; Chang JY; Gau CS; Luo N; Pickard AS; Ramos Goñi JM; Tang CH; Hsu CN
PLoS One; 2024; 19(6):e0305983. PubMed ID: 38889178
[TBL] [Abstract][Full Text] [Related]
9. Modeling Misspecification as a Parameter in Bayesian Structural Equation Models.
Uanhoro JO
Educ Psychol Meas; 2024 Apr; 84(2):245-270. PubMed ID: 38898883
[TBL] [Abstract][Full Text] [Related]
10. Overview, Update, and Lessons Learned From the International EQ-5D-5L Valuation Work: Version 2 of the EQ-5D-5L Valuation Protocol.
Stolk E; Ludwig K; Rand K; van Hout B; Ramos-Goñi JM
Value Health; 2019 Jan; 22(1):23-30. PubMed ID: 30661630
[TBL] [Abstract][Full Text] [Related]
11. EQ-5D-Y as a Health-Related Quality of Life Instrument for Children and Adolescents: The Instrument's Characteristics, Development, Current Use, and Challenges of Developing Its Value Set.
Kreimeier S; Greiner W
Value Health; 2019 Jan; 22(1):31-37. PubMed ID: 30661631
[TBL] [Abstract][Full Text] [Related]
12. Creating a Multiply Imputed Value Set for the EQ-5D-5L in Canada: State-Level Misspecification Terms Are Needed to Characterize Parameter Uncertainty Correctly.
Tsui TCO; Chan KKW; Xie F; Pullenayegum EM
Med Decis Making; 2024 May; 44(4):405-414. PubMed ID: 38591189
[TBL] [Abstract][Full Text] [Related]
13. Bayesian Models with Spatial Correlation Improve the Precision of EQ-5D-5L Value Sets.
Che M; Xie F; Thomas S; Pullenayegum E
Med Decis Making; 2023 Jul; 43(5):587-594. PubMed ID: 37243474
[TBL] [Abstract][Full Text] [Related]
14. Quantifying Parameter Uncertainty in EQ-5D-3L Value Sets and Its Impact on Studies That Use the EQ-5D-3L to Measure Health Utility: A Bayesian Approach.
Pullenayegum EM; Chan KK; Xie F
Med Decis Making; 2016 Feb; 36(2):223-33. PubMed ID: 26139449
[TBL] [Abstract][Full Text] [Related]
15. Less Is More: Cross-Validation Testing of Simplified Nonlinear Regression Model Specifications for EQ-5D-5L Health State Values.
Rand-Hendriksen K; Ramos-Goñi JM; Augestad LA; Luo N
Value Health; 2017; 20(7):945-952. PubMed ID: 28712624
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
